Puig-Gámez Marta, Van Attekum Martijn, Theis Theodor, Dick Alec, Park John E
Department of Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, 88387, Biberach an der Riss, Germany.
Department of Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, 88387, Biberach an der Riss, Germany.
Sci Rep. 2025 Mar 28;15(1):10769. doi: 10.1038/s41598-025-95211-7.
Natural killer (NK) cells are prototypic cytotoxic innate lymphocytes that can kill target cells, such as tumor cells, in the absence of antigen-restriction. Peripheral NK cells exhibit a high degree of heterogeneity. Here, we set out to broadly assess intrinsic modulators of NK cell degranulation in an unbiased manner. We stimulated human primary blood-borne NK cells pre-treated with different cytokine regimens with the HCT116 human colon cancer cell line and used detection of lysosome-associated membrane glycoprotein 1 (LAMP1) as an identifier of rapid NK cell degranulation. RNA sequencing of FACS-sorted LAMP1 NK cells showed CXCR4 and S1PR5 were top down-regulated genes. Using compounds that modulate activity of CXCR4 and S1P receptor family members S1P1 and S1P5, we confirmed they play an important immunosuppressive role in NK cell cytotoxicity. Mechanistically, engagement of CXCR4 and S1P1/5 receptors triggered phosphorylation of p42 and Ca influx. CXCR4 activation promoted S1P5 upregulation and vice versa, and joint activation of both receptors amplified the defect NK cell degranulation. Intriguingly, in tumor samples the expression of both receptors and the synthesis of their ligands themselves appear to be coordinately regulated. Together, these data suggest that specifically and simultaneously targeting CXCR4 and S1P5 activity in the tumor microenvironment (TME) could be a beneficial strategy to unleash full cytotoxic potential of cytotoxic NK effector cells in the tumor.
自然杀伤(NK)细胞是典型的细胞毒性固有淋巴细胞,能够在无抗原限制的情况下杀伤靶细胞,如肿瘤细胞。外周血NK细胞表现出高度的异质性。在此,我们旨在以无偏倚的方式广泛评估NK细胞脱颗粒的内在调节因子。我们用HCT116人结肠癌细胞系刺激经不同细胞因子方案预处理的人原发性血源NK细胞,并使用溶酶体相关膜糖蛋白1(LAMP1)的检测作为快速NK细胞脱颗粒的标志物。对通过荧光激活细胞分选术(FACS)分选的LAMP1 NK细胞进行RNA测序,结果显示CXCR4和S1PR5是下调最明显的基因。使用调节CXCR4以及S1P受体家族成员S1P1和S1P5活性的化合物,我们证实它们在NK细胞细胞毒性中发挥重要的免疫抑制作用。从机制上讲,CXCR4和S1P1/5受体的结合触发了p42的磷酸化和钙离子内流。CXCR4的激活促进了S1P5的上调,反之亦然,两种受体的联合激活放大了NK细胞脱颗粒缺陷。有趣的是,在肿瘤样本中,这两种受体的表达及其配体自身的合成似乎受到协同调节。总之,这些数据表明,在肿瘤微环境(TME)中特异性且同时靶向CXCR4和S1P5的活性可能是释放细胞毒性NK效应细胞在肿瘤中的全部细胞毒性潜能的有益策略。